Genetics/Genomes/Proteomics/Metabolomics

Clinical and Molecular Prevalence of Lipodystrophy in an Unascertained Large Clinical Care Cohort

  1. Claudia Gonzaga-Jauregui1⇑,
  2. Wenzhen Ge2,
  3. Jeffrey Staples1,
  4. Cristopher Van Hout1,
  5. Ashish Yadav1,
  6. Ryan Colonie3,
  7. Joseph B. Leader3,
  8. H. Lester Kirchner3,
  9. Michael F. Murray3,
  10. Jeffrey G. Reid1,
  11. David J. Carey3,
  12. John D. Overton1,
  13. Alan R. Shuldiner1,
  14. Omri Gottesman1,
  15. Steve Gao2,
  16. Jesper Gromada2,
  17. Aris Baras1 and
  18. Judith Altarejos2⇑ on behalf of the Geisinger-Regeneron DiscovEHR collaboration
  1. 1Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  2. 2Regeneron Pharmaceuticals, Inc., Tarrytown, NY
  3. 3Geisinger Health System, Danville, PA
  1. Corresponding authors: Judith Altarejos, judith.altarejos{at}regeneron.com, and Claudia Gonzaga-Jauregui, clau.gonzagajauregui{at}regeneron.com
Diabetes 2020 Feb; 69(2): 249-258. https://doi.org/10.2337/db19-0447

Data supplements

Back to top
View Selected Citations (0)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Add to Selected Citations

Clinical and Molecular Prevalence of Lipodystrophy in an Unascertained Large Clinical Care Cohort
Claudia Gonzaga-Jauregui, Wenzhen Ge, Jeffrey Staples, Cristopher Van Hout, Ashish Yadav, Ryan Colonie, Joseph B. Leader, H. Lester Kirchner, Michael F. Murray, Jeffrey G. Reid, David J. Carey, John D. Overton, Alan R. Shuldiner, Omri Gottesman, Steve Gao, Jesper Gromada, Aris Baras, Judith Altarejos
Diabetes Feb 2020, 69 (2) 249-258; DOI: 10.2337/db19-0447
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section